Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 55 Records) |
| Query Trace: Breast Neoplasms and HLA-E[original query] |
|---|
| Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer. Immunogenetics 2016 Sep . Alomar Suliman Y, Alkhuriji Afrah, Trayhyrn Paul, Alhetheel Abdulkarim, Al-Jurayyan Abdullah, Mansour Lamj |
| Immune DNA signature of T-cell infiltration in breast tumor exomes. Scientific reports 2016 6 30064. Levy Eric, Marty Rachel, Gárate Calderón Valentina, Woo Brian, Dow Michelle, Armisen Ricardo, Carter Hannah, Harismendy Olivi |
| KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors. Frontiers in immunology 2016 7 561. Morales-Estevez Cristina, De la Haba-Rodriguez Juan, Manzanares-Martin Barbara, Porras-Quintela Ignacio, Rodriguez-Ariza Antonio, Moreno-Vega Alberto, Ortiz-Morales Maria J, Gomez-España Maria A, Cano-Osuna Maria T, Lopez-Gonzalez Javier, Chia-Delgado Beatriz, Gonzalez-Fernandez Rafael, Aranda-Aguilar Enriq |
| Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes. The pharmacogenomics journal 2017 8 18 (3): 480-486. Spraggs C F, Parham L R, Briley L P, Warren L, Williams L S, Fraser D J, Jiang Z, Aziz Z, Ahmed S, Demetriou G, Mehta A, Jackson N, Byrne J, Andersson M, Toi M, Harris L, Gralow J, Zujewski J A, Crescenzo R, Armour A, Perez E, Piccart |
| Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients. Oncology research 2017 Mar . Todorova Valentina K, Makhoul Issam, Dhakal Ishwori, Wei Jeanne, Stone Annjanette, Carter Weleetka, Owen Aaron, Klimberg V Suzan |
| The Impact of HLA-G 3'UTR Polymorphisms in Breast Cancer in a Tunisian Population. Immunological investigations 2019 Apr 1-12. Ouni Nesrine, Chaaben Arij Ben, Kablouti Ghalia, Ayari Fayza, Douik Hayet, Abaza Hajer, Gara Sonia, Elgaaied-Benammar Amel, Guemira Fethi, Tamouza Ry |
| Association of HLA-G 3'UTR 14-bp Ins/Del polymorphism with breast cancer among South Indian women. Journal of clinical pathology 2019 Dec . Kadiam Sony, Ramasamy Thirunavukkarasu, Ramakrishnan Revathi, Mariakuttikan Jayalaksh |
| Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania. Asian Pacific journal of cancer prevention : APJCP 2019 Nov 20 (11): 3465-3472. Adolf Ismael Chatita, Akan Gokce, Mselle Teddy F, Dharsee Nazima, Namkinga Lucy A, Atalar Fatmah |
| Breast Cancer Is Associated with Increased HLA-DRB1*11:01 and HLA-DRB1*10:01 Allele Frequency in a Population of Patients from Central Italy. Immunological investigations 2020 3 49 (5): 489-497. Aureli Anna, Canossi Angelica, Del Beato Tiziana, Buonomo Oreste, Rossi Piero, Roselli Mario, Papola Franco, Marziani Beatrice, Sconocchia Giusep |
| Certain haplotypes of the 3'-UTR region of the HLA-G gene are linked to breast cancer. British journal of biomedical science 2020 11 78 (2): 87-91. Haghi M, Ranjbar M, Karari K, Samadi-Miandoab S, Eftekhari A, Hosseinpour-Feizi M |
| Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis. Frontiers in molecular biosciences 2020 11 7 569414. Song Jukun, Han Jing, Liu Feng, Chen Xianlin, Qian Shenqi, Wang Yadong, Jia Zhenyu, Duan Xiaofeng, Zhang Xiangyan, Zhu Jiang |
| Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk. Scientific reports 2021 Apr 11 (1): 7932. Ashouri Elham, Rajalingam Karan, Barani Shaghik, Farjadian Shirin, Ghaderi Abbas, Rajalingam Ra |
| Relationship between HLA-DRB1 gene polymorphism and breast cancer: A protocol for systematic review and meta-analysis. Medicine 2021 Mar 100 (12): e25078. Liu Linlin, Sun Xu, Yuan Chenxi, Liu Huaim |
| The Association of Estrogen Receptor Activity, Interferon Signaling, and MHC Class I Expression in Breast Cancer. Cancer research and treatment 2021 12 54 (4): 1111-1120. Song In Hye, Kim Young-Ae, Heo Sun-Hee, Bang Won Seon, Park Hye Seon, Choi Yeon Ho, Lee Heejae, Seo Jeong-Han, Cho Youngjin, Jung Sung Wook, Kim Hee Jeong, Ahn Sei Hyun, Lee Hee Jin, Gong Gyungy |
| Genetic polymorphisms on the effectiveness or safety of breast cancer treatment: Clinical relevance and future perspectives. Mutation research. Reviews in mutation research 2021 12 788 108391. Cura Yasmin, Pérez Ramírez Cristina, Sánchez Martín Almudena, Martínez Martínez Fernando, Calleja Hernández Miguel Ángel, Ramírez Tortosa María Del Carmen, Jiménez Morales Alber |
| Carriage of HLA-DRB1*11 and 1*12 alleles and risk factors in patients with breast cancer in Burkina Faso. Open life sciences 2021 10 16 (1): 1101-1110. Zouré Abdou Azaque, Amegnona Lanyo Jospin, Zongo Nayi, Kiendrebeogo Isabelle Touwendpoulimdé, Sorgho Pegdwendé Abel, Zongo Fabienne Ingrid, Yonli Albert Théophane, Sombié Herman Karim, Bambara Aboubacar Hierrhum, Sawadogo Alexis Yobi, Ouedraogo Marie N L, Traoré Lassina, Zongo Sidnooma Véronique, Lallogo Doriane Tatiana, Bazié Bapio Valery Jean Télesphore Elvira, Zohoncon Théodora M, Dijgma Florencia W, Simpore Jacqu |
| Pro-inflammatory cytokine polymorphisms and interactions with dietary alcohol and estrogen, risk factors for invasive breast cancer using a post genome-wide analysis for gene-gene and gene-lifestyle interaction. Scientific reports 2021 Jan 11 (1): 1058. Jung Su Yon, Papp Jeanette C, Sobel Eric M, Pellegrini Matteo, Yu Herbert, Zhang Zuo-Fe |
| 3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis. Immunology letters 2022 Jun 248 78-89. Tizaoui Kalthoum, Jalouli Maroua, Ouzari Hadda-Imene, Harrath Abdel Halim, Rizzo Roberta, Boujelbene Nadia, Zidi In |
| Relevance of the MHC region for breast cancer susceptibility in Asians. Breast cancer (Tokyo, Japan) 2022 May . Ho Peh Joo, Khng Alexis Jiaying, Tan Benita Kiat-Tee, Tan Ern Yu, Tan Su-Ming, Tan Veronique Kiak Mien, Lim Geok Hoon, Aronson Kristan J, Chan Tsun L, Choi Ji-Yeob, Dennis Joe, Ho Weang-Kee, Hou Ming-Feng, Ito Hidemi, Iwasaki Motoki, John Esther M, Kang Daehee, Kim Sung-Won, Kurian Allison W, Kwong Ava, Lophatananon Artitaya, Matsuo Keitaro, Mohd-Taib Nur Aishah, Muir Kenneth, Murphy Rachel A, Park Sue K, Shen Chen-Yang, Shu Xiao-Ou, Teo Soo Hwang, Wang Qin, Yamaji Taiki, Zheng Wei, Bolla Manjeet K, Dunning Alison M, Easton Douglas F, Pharoah Paul D P, Hartman Mikael, Li Jingm |
| Accurate genome-wide genotyping from archival tissue to explore the contribution of common genetic variants to pre-cancer outcomes. Journal of translational medicine 2022 12 20 (1): 623. Nachmanson Daniela, Pagadala Meghana, Steward Joseph, Cheung Callie, Bruce Lauryn Keeler, Lee Nicole Q, O'Keefe Thomas J, Lin Grace Y, Hasteh Farnaz, Morris Gerald P, Carter Hannah, Harismendy Olivi |
| Inositol 1,4,5-trisphosphate receptor gene variants are related to the risk of breast cancer in a Chinese population. The journal of gene medicine 2022 11 25 (2): e3463. Chen Jiaping, Zhou Jing, Jiang Yue, Wang Yuzhuo, Chen Congcong, Jiang Tao, Du Jiang |
| KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer. Frontiers in immunology 2022 1 12 791958. Muraro Elena, De Zorzi Mariangela, Miolo Gianmaria, Lombardi Davide, Scalone Simona, Spazzapan Simon, Massarut Samuele, Perin Tiziana, Dolcetti Riccardo, Steffan Agostino, De Re Val |
| Invasive Breast Cancer: miR-24-2 Targets Genes Associated with Survival and Sensitizes MDA-MB-231 Cells to Berberine. Omics : a journal of integrative biology 2023 9 . Mansoor Ali, Rameshwar N K Bamezai, Rana P Sin |
| HLA-G 14 bp Ins/Del (rs66554220) Variant Is Not Associated with Breast Cancer in Women from Western Mexico. Current issues in molecular biology 2023 8 45 (8): 6842-6850. Denisse Stephania Becerra-Loaiza, Luisa Fernanda Roldan Flores, Luis Antonio Ochoa-Ramírez, Bricia M Gutiérrez-Zepeda, Alicia Del Toro-Arreola, Ramón Antonio Franco-Topete, Andrés Morán-Mendoza, Antonio Oceguera-Villanueva, Antonio Topete, David Javalera, Antonio Quintero-Ramos, Adrián Daneri-Navar |
| Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients. Frontiers in immunology 2023 6 14 1188030. Oliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, Julian Hölzenbein, Esther Schwich, Sabine Schramm, Hana Rohn, Peter A Horn, Rainer Kimmig, Sabine Kasimir-Bauer, Vera Rebma |
| Identification of genetic and immune signatures for the recurrence of HER2-positive breast cancer after trastuzumab-based treatment. Breast cancer research and treatment 2023 4 . Chi Xu, Yahui Wang, Yuanyuan Hong, Ru Yao, Lijia Wu, Xi Shen, Yang Qu, Zhuo Zhang, Wei Zhu, Ying Yang, Weizhi Chen, Yidong Zhou, Zhiyong Lia |
| Integration of exome-seq and mRNA-seq using DawnRank, identified genes involved in innate immunity as drivers of breast cancer in the Indian cohort. PeerJ 2023 10 11 e16033. Snehal Nirgude, Sagar Desai, Vartika Khanchandani, Vidhyavathy Nagarajan, Jayanti Thumsi, Bibha Choudha |
| HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles. Breast cancer research and treatment 2024 9 . Ekaterina S Kuligina, Alexandr A Romanko, Tatjana Jankevic, Aleksandr S Martianov, Alexandr O Ivantsov, Tatyana N Sokolova, Dmitry Trofimov, Aniruddh Kashyap, Cezary Cybulski, Jan Lubi?ski, Evgeny N Imyanit |
| A comprehensive analysis of germline predisposition to early-onset ovarian cancer. Scientific reports 2024 7 14 (1): 16183. Klara Horackova, Petra Zemankova, Petr Nehasil, Michal Vocka, Milena Hovhannisyan, Katerina Matejkova, Marketa Janatova, Marta Cerna, Petra Kleiblova, Sandra Jelinkova, Barbora Stastna, Pavel Just, Tatana Dolezalova, Barbora Nemcova, Marketa Urbanova, Monika Koudova, Jana Hazova, Eva Machackova, Lenka Foretova, Viktor Stranecky, Michal Zikan, Zdenek Kleibl, Jana Soukupo |
| Construction and significance of a breast cancer prognostic model based on cuproptosis-related genotyping and lncRNAs. Journal of the Formosan Medical Association = Taiwan yi zhi 2024 5 . Lu Sun, Xinxu Chen, Fei Li, Shengchun L |
- Page last reviewed:Feb 1, 2024
- Content source: